CATH Domain 5vp1B00

Level	CATH Code	Description
	1	Mainly Alpha
	1.10	Orthogonal Bundle
	1.10.1300	Catalytic domain of cyclic nucleotide phosphodiesterase 4b2b
	1.10.1300.10	3'5'-cyclic nucleotide phosphodiesterase, catalytic domain

Superfamily	3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
Functional Family	Phosphodiesterase

3.1.4.17

3',5'-cyclic-nucleotide phosphodiesterase.

based on mapping to UniProt O00408

Nucleoside 3',5'-cyclic phosphate + H(2)O = nucleoside 5'-phosphate.

-!- Acts on 3',5'-cyclic AMP, 3',5'-cyclic dAMP, 3',5'-cyclic IMP, 3',5'-cyclic GMP and 3',5'-cyclic CMP.

PDE2A_HUMAN

Homo sapiens

CGMP-dependent 3',5'-cyclic phosphodiesterase

PDB	5VP1
External Links	PDBSum Proteopedia
Method	X-RAY DIFFRACTION
Organism
Primary Citation	Discovery of a Novel Series of Pyrazolo[1,5-a]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), for the Treatment of Cognitive Disorders. Mikami, S., Kawasaki, M., Ikeda, S., Negoro, N., Nakamura, S., Nomura, I., Ashizawa, T., Kokubo, H., Hoffman, I.D., Zou, H., Oki, H., Uchiyama, N., Hiura, Y., Miyamoto, M., Itou, Y., Nakashima, M., Iwashita, H., Taniguchi, T. Chem. Pharm. Bull.